Claris Biotherapeutics announced it raised $10 Million in an initial filing from an offering of $10 Million

Jan 08, 2024•almost 2 years ago

Amount Raised

$10 Million

Jersey CityBiotechnology

Company Information

Company

Claris Biotherapeutics

Location

299 PAVONIA AVENUE 3-8

Jersey City, New Jersey, United States

About

Claris Biotherapeutics develops a topical formulation intended to cure corneal wounds, ulcers, and scars. The formulation creates a recombinant hepatocyte growth factor which accelerates the healing process, providing healthcare providers noninvasive therapeutic treatment.

Related People

2 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Claris Biotherapeutics announced it raised $10 Million in an initial filing from an offering of $10 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information